SCHEMBL4078655

SCHEMBL4078655

CCC(Br)CCC(=O)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7368419 0.85 ALDH1A1 (0.50)
SCHEMBL11677952 0.80 ALDH1A1 (0.54)
SCHEMBL5654012 0.78
SCHEMBL143442 0.78
SCHEMBL28335814 0.76 GABRP (0.44)
SCHEMBL666348 0.75
SCHEMBL5924687 0.75 TSHR (0.50)
SCHEMBL4754955 0.75
SCHEMBL1605180 0.74
SCHEMBL11370272 0.73 TSHR (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4662211-A1 G PROTEIN-COUPLED RECEPTOR KINASE 2 (GRK2) DEGRADATION COMPOUNDS AND USE THEREOF Nanjing Huanbo Biotechnology Co., Ltd. (CN) 2025-12-17 EP disclosed
WO-2024165075-A1 G PROTEIN-COUPLED RECEPTOR KINASE 2 (GRK2) DEGRADATION COMPOUNDS AND USE THEREOF NANJING HUANBO BIOTECHNOLOGY CO., LTD. (CN) 2024-08-15 WO disclosed
US-9045494-B2 Orthoester compound NEKTAR THERAPEUTICS (US) 2015-06-02 US disclosed
US-20140296541-A1 ORTHOESTER COMPOUND NEKTAR THERAPEUTICS 2014-10-02 US disclosed
US-8784791-B2 Method for preparing water-soluble polymer derivatives bearing an N-succinimidyl ester NEKTAR THERAPEUTICS (US) 2014-07-22 US disclosed
US-20130231490-A1 METHOD FOR PREPARING WATER-SOLUBLE POLYMER DERIVATIVES BEARING AN N-SUCCINIMIDYL ESTER NEKTAR THERAPEUTICS (US) 2013-09-05 US disclosed
US-8435504-B2 Method for preparing water-soluble polymer derivatives bearing a terminal carboxylic acid NEKTAR THERAPEUTICS (US) 2013-05-07 US disclosed
US-20120209027-A1 Method for Preparing Water-Soluble Polymer Derivatives Bearing a Terminal Carboxylic Acid NEKTAR THERAPEUTICS (US) 2012-08-16 US disclosed
US-8182801-B2 Method for preparing water-soluble polymer derivatives bearing a terminal carboxylic acid NEKTAR THERAPEUTICS (US) 2012-05-22 US disclosed
US-20090264600-A1 Method for Preparing Water-Soluble Polymer Derivatives Bearing a Terminal Carboxylic Acid NEKTAR THERAPEUTICS AL, CORPORATION (US) 2009-10-22 US disclosed
US-7569214-B2 Hydrolysing water-soluble polyoxyethylene glycol segment having alkoxide ion or thiolate ion with ortho ester comprised of suitable leaving group (methanesulfonate) NEKTAR THERAPEUTICS AL, CORPORATION (US) 2009-08-04 US disclosed
EP-1537163-B1 METHOD FOR PREPARING WATER-SOLUBLE POLYMER DERIVATIVES BEARING A TERMINAL CARBOXYLIC ACID NEKTAR THERAPEUTICS AL CORP (US) 2008-10-29 EP disclosed
EP-1537163-A2 METHOD FOR PREPARING WATER-SOLUBLE POLYMER DERIVATIVES BEARING A TERMINAL CARBOXYLIC ACID Nektar Therapeutics Al, Corporation (US) 2005-06-08 EP disclosed
US-20050036978-A1 Hydrolysing water-soluble polyoxyethylene glycol segment having alkoxide ion or thiolate ion with ortho ester comprised of suitable leaving group (methanesulfonate) NEKTAR THERAPEUTICS 2005-02-17 US disclosed
WO-2004022629-A2 METHOD FOR PREPARING WATER-SOLUBLE POLYMER DERIVATIVES BEARING A TERMINAL CARBOXYLIC ACID NEKTAR THERAPEUTICS AL, CORPORATION (US) 2004-03-18 WO disclosed